Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
Public ClinicalTrials.gov record NCT03961698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ph 2, Multi-arm, Multicenter, Open-label Study to Evaluate Efficacy and Safety of IPI-549 Administered in Combo With Front-line Treatment Regimens in Pts With Locally Advanced and/or Metastatic Triple-Negative Breast Cancer or Renal Cell Carcinoma
Study identification
- NCT ID
- NCT03961698
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Infinity Pharmaceuticals, Inc.
- Industry
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Interventions
- Atezolizumab Drug
- Bevacizumab Drug
- IPI-549 (eganelisib) Drug
- nab-paclitaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2019
- Primary completion
- Aug 30, 2023
- Completion
- Aug 30, 2023
- Last update posted
- Aug 13, 2023
2019 – 2023
United States locations
- U.S. sites
- 24
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer and Research Center | Chandler | Arizona | 85224 | — |
| Arizona Oncology Associates | Tucson | Arizona | 85704 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| St. Joseph Heritage Healthcare | Fullerton | California | 92835 | — |
| Cancer & Blood Specialty Clinic | Los Alamitos | California | 90720 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Samsum Clinic | Santa Barbara | California | 93105 | — |
| UCLA | Santa Monica | California | 90404 | — |
| Olive View - UCLA Medical Center | Sylmar | California | 91342 | — |
| Valley Breast Cancer Care and Women's Health Center | Van Nuys | California | 15211 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| University Cancer & Blood Center | Athens | Georgia | 30607 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | 46804 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40207 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| UT Health East Texas HOPE Cancer Center | Tyler | Texas | 75701 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03961698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2023 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03961698 live on ClinicalTrials.gov.